Torthaí cuardaigh - Peter Buontempo

  • 1 - 2 toradh as 2 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120

    Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120 de réir Robert A. Ogert, Lisa Wojcik, Catherine Buontempo, Lei Ba, Peter Buontempo, Robert Ralston, Julie Strizki, John A. Howe

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of the three poliovirus serotypes

    Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of the three poliovirus serotypes de réir Karen N Lentz, Allen Smith, Sheila C. Geisler, Stuart Cox, Peter Buontempo, Angela Skelton, Jason DeMartino, Edward J. Rozhon, Jerome Schwartz, Viyyoor Girijavallabhan, John F. O’Connell, Eddy Arnold

    Foilsithe / Cruthaithe 1997
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: